kelatorphan has been researched along with enkephalin, leucine-2-alanine in 1 studies
| Studies (kelatorphan) | Trials (kelatorphan) | Recent Studies (post-2010) (kelatorphan) | Studies (enkephalin, leucine-2-alanine) | Trials (enkephalin, leucine-2-alanine) | Recent Studies (post-2010) (enkephalin, leucine-2-alanine) |
|---|---|---|---|---|---|
| 58 | 0 | 1 | 1,581 | 23 | 74 |
| Protein | Taxonomy | kelatorphan (IC50) | enkephalin, leucine-2-alanine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0915 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.009 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0419 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 1.4691 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouboutou, R; Devin, J; Fournié-Zaluski, MC; Roques, BP; Waksman, G | 1 |
1 other study(ies) available for kelatorphan and enkephalin, leucine-2-alanine
| Article | Year |
|---|---|
Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
Topics: Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Chromatography, Gel; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Hydroxamic Acids; Rabbits; Rats; Structure-Activity Relationship | 1984 |